Heavy Metal Poisoning: Clinical Trials

4 trials for Heavy Metal Poisoning, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown, 1 withdrawn. 4 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 1, Recruiting 1, Unknown 1, Withdrawn 1
Phase 32Unknown 1, Withdrawn 1

Follow Heavy Metal Poisoning: new trials by email Literature Review of Heavy Metal Poisoning trials Research Report on Heavy Metal Poisoning

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Safety and Efficacy of GMDTC for Injection in Subjects With Elevated Cadmium Levels
GMDTC for injection, 0.9% Sodium Chloride Injection(0.9% NaCl) - Cadmium Exceeds the Standard
Phase 2RecruitingGuangdong Jianersheng Pharmaceutical Technology Co., Ltd.112025-07-072025-09-02
NBMI Treatment in Patients With Mercury Toxicity
(N1, N3-bis(2- mercaptoethyl)isophthalamide), Excipients microcrystalline cellulose, silica and magnesium stearate - Mercury Poisoning
Phase 2 / Phase 3UnknownEmeraMed1162023-11-222024-03-12
Pilot Proof of Concept Study of NBMI Treatment of Mercury Intoxication
Emeramide, Placebo - Mercury Poisoning
Phase 2CompletedEmeraMed362015-08-012021-03-08
Penicillamine Chelation for Children With Lead Poisoning
d-penicillamine, placebo - Lead Poisoning, Vitamin D Deficiency
Phase 2 / Phase 3WithdrawnFDA Office of Orphan Products Development2007-09-012015-03-26

Narrower conditions

Mercury Poisoning (2)  ·  Cadmium Poisoning (1)  ·  Lead Poisoning (1)  ·  Vitamin D Deficiency (1)

Broader conditions

Chemically-Induced Disorders (4)  ·  Poisoning (4)  ·  Avitaminosis (1)  ·  Deficiency Diseases (1)  ·  Malnutrition (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Injections (1)  ·  N,N'-Bis(2-mercaptoethyl)isophthalamide (1)  ·  Silicon Dioxide (1)  ·  Sodium Chloride (1)  ·  stearic acid (1)

Sponsors

EmeraMed (2)  ·  FDA Office of Orphan Products Development (1)  ·  Guangdong Jianersheng Pharmaceutical Technology Co., Ltd. (1)

Countries

China (1)  ·  Colombia (1)  ·  Ecuador (1)  ·  United States (1)

Top investigators

Andres Cadena-Bonfanti, MD (1)  ·  Augusto Focil Baquerizo, MD (1)  ·  Michael W Shannon, MD (1)  ·  Ming Huang, PhD (1)  ·  Yanyan Wang, M.Med. (1)

Results publications

PMID 29444690